- £1.96bn
- £2.24bn
- £1.58bn
- 54
- 44
- 59
- 51
2019 March 31st | 2020 March 31st | 2021 March 31st | C2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 911 | 1,073 | 1,278 | 1,320 | 1,581 |
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 788 | 949 | 1,159 | 1,193 | 1,382 |
Operating Profit | 123 | 124 | 119 | 127 | 199 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 123 | 123 | 146 | 126 | 192 |
Provision for Income Taxes | |||||
Net Income After Taxes | 114 | 107 | 125 | 90 | 154 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 114 | 106 | 125 | 90 | 154 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 114 | 106 | 125 | 90 | 154 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.205 | 0.192 | 0.208 | 0.145 | 0.233 |
Dividends per Share |